US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
DMG Mori AG (GIL) 銘柄情報

DMG Mori AG (GIL)

46.90

0.00

( 0.00% )

更新日時： 14:06:19

DMG Mori AG (GIL) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

46.90

( - )

買値

46.80

売値

47.00

出来高

0.00

0.00 日の範囲 0.00

45.60 52 週間の範囲 49.00

時価総額

前日終値

46.90

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

2,354 €

発行済株式数

78,817,994

配当利回り

(2.15%)

PER

47.41

1 株当たり利益 (EPS)

-

歳入

2.1B

純利益

179.75M

DMG MORI AKTIENGESELLSCHAFT engages in the manufacture and sale of cutting machine tools in Germany, rest of the Europe, the United States, Asia, and internationally. The company operates through Machine Tools and Industrial Services segments. The Machine Tools segment offers a portfolio of turning ... DMG MORI AKTIENGESELLSCHAFT engages in the manufacture and sale of cutting machine tools in Germany, rest of the Europe, the United States, Asia, and internationally. The company operates through Machine Tools and Industrial Services segments. The Machine Tools segment offers a portfolio of turning machines, such as universal turning machines, turn-mill centers, production turning, and multi-spindle machining centers; vertical and horizontal centers, and 5-axis milling products; ultrasonic, lasertec, and additive manufacturing products; and selective laser melting in the powder bed, as well as control and software development solutions. The Industrial Services segment provides industrial services, including service agreements, maintenance, repair, and training services, as well as services related to spare parts. It serves aviation and space, data and semiconductor, die and mold, mobility and medical, education, energy, and job shop sectors. DMG MORI AKTIENGESELLSCHAFT was founded in 1870 and is based in Bielefeld, Germany. 詳細を表示

セクター

Industrials

業界

Industrial Goods

ウェブサイト

www.dmgmori.com

本社

Bielefeld, Germany

設立

1870

DMG Mori AG is listed in the Industrials sector of the Tradegate (DE) with ticker GIL. The last closing price for DMG Mori was 46.90 €. Over the last year, DMG Mori shares have traded in a share price range of 45.60 € to 49.00 €.

DMG Mori currently has 78,817,994 shares in issue. The market capitalisation of DMG Mori is 3.70 € billion. DMG Mori has a price to earnings ratio (PE ratio) of 47.41.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.1	-0.212765957447	47	47	46.7	689	46.8304878	DE
4	-0.1	-0.212765957447	47	47.4	46.5	689	46.92033677	DE
12	-1.3	-2.69709543568	48.2	48.8	46.5	773	47.70193203	DE
26	0.3	0.643776824034	46.6	49	46.5	759	47.59018477	DE
52	0.8	1.73535791757	46.1	49	45.6	681	47.0011178	DE
156	4.4	10.3529411765	42.5	49	42.1	963	44.44139732	DE
260	5.5	13.2850241546	41.4	49	39.7	1562	42.60931235	DE

GIL - Frequently Asked Questions (FAQ)

What is the current DMG Mori AG share price?

The current share price of DMG Mori AG is 46.90 €

How many DMG Mori AG shares are in issue?

DMG Mori AG has 78,817,994 shares in issue

What is the market cap of DMG Mori AG?

The market capitalisation of DMG Mori AG is EUR 3.7B

What is the 1 year trading range for DMG Mori AG share price?

DMG Mori AG has traded in the range of 45.60 € to 49.00 € during the past year

What is the PE ratio of DMG Mori AG?

The price to earnings ratio of DMG Mori AG is 47.41

What is the cash to sales ratio of DMG Mori AG?

The cash to sales ratio of DMG Mori AG is 1.75

What is the registered address of DMG Mori AG?

The registered address for DMG Mori AG is Gildemeisterstrasse 60, Bielefeld, North Rhine-Westphalia, 33689

What is the DMG Mori AG website address?

The website address for DMG Mori AG is www.dmgmori.com

Which industry sector does DMG Mori AG operate in?

DMG Mori AG operates in the Industrial Goods sector

HyGro

Sorry, not enough. NWBO won't make any profit selling in the UK. NICE hates personalized oncology treatments and won't pay enough for NWBO to make a profit.
That's what counts. And NWBO will go under or just become Advent Contract Manufacturer. They have no cash or credit to fund any sub

biotechinvestor1

biotechinvestor1 7分前

Don’t start spazzing again, Alteogen circus clown. The Sanofi news is old.
Once Merck settles/licenses from Halozyme, Sanofi and all others will follow.
Your Alteogen stole IP from Halozyme and will pay a price for it. You can count on it.
The companies who have signed with Alte

Steady_T

Steady_T 7分前

Your theory will be put to the test after UK approval. I give it 6 months as a guess.

HyGro

What's true is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How many years are you going to wait to find out???

HyGro

What's True is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How long are you going to wait to find out???

Mdk1

Google Scholar alert - new article: "A Comparison of Plasmonic Modulator Structures in the O- and C-Band for the 400G/Lane IM/DD Era"
>>> " In ALL cases, the same electro-optic organic material, Lightwave Logic’s PerkinamineTM
chromophore series 3, was used " !
https://ieeexplor

CelestialSage6

CelestialSage6 15分前

Stop talking nonsense. Sanofi is conducting clinical trials using Alteogen's technology; what are your thoughts on this? Did you sense a crisis for Halozyme?

biotechinvestor1

biotechinvestor1 17分前

I love it when Alteogen fanboys post on this board. Nearly every time they show up, Halozyme has a run up.

DR_rugby

DR_rugby 18分前

Prophecy is coming

https://www.cnbc.com/2026/06/16/boj-rate-hike-historic-inflation.html

Japanese rates are going higher

Yen is yet to be stabilize

The great unwinding is coming soon

GLTA

BigBadWolf

BigBadWolf 25分前

Authorized Shares 1,800,000,000 06/15/2026
Outstanding Shares 1,619,034,363 06/15/2026 >5m
Restricted 480,530,670 06/15/2026 >5m
Unrestricted 1,138,503,693 06/15/2026
Held at DTC 1,011,499,104 06/15/2026 >8m

Authorized Shares 1,800,000,000 06/05/2026

4retire

4retire 28分前

One has to question why a “cash rich” company would need to raise $20-25 billion by going to bond sales that will be in 7 tranches, ranging from 2 to 30 years. The statement is that it’s for general purposes and to redo some current debt financing.

Based on recent financials, NVDA’

tank777

tank777 28分前

FACT CHECK:

The key distinction is between “eligible” and “selected.”

To date, CMS has not publicly released a list of approved CBD brands for the Substance Access Beneficiary Engagement Incentive (BEI) program.

That means:

Mr. Tate

Mr. Tate 29分前

Your Mother should've named you loser0. Awww did someone take your lunch money in school loser0? IMO

jhdf51

jhdf51 29分前

Great.. thank you.

ducci1

ducci1 30分前

Pivot Calcs: SPX Pivot 7549---R1 7582---S1 7521---SPY Pivot 754---R1 757---S1 752----ES Pivot 7601---R1 7667---S1 7555----VIX Pivot 16.35---R1 16.70---S1 15.85---15 min Bull/Bear R/Line 18.34!----!!LOL!!

Mr. Tate

Mr. Tate 30分前

Are you for real loser0? You always hide behind a computer screen loser0? IMO

Wolf-man jack

Wolf-man jack 35分前

WQLF SAYS: .Charlottes Web products Have Not been PUBLICLY STATED as being OFFICIALLY APPROVED. In the case of CV SCIENCES, the CMS Pilot Program still has time to Announce CV SCIENCES or are they already enrolled? Cornbread was never announced, so one can not reliably state that it is A True FACT Y

knrorrel

knrorrel 47分前

Wow, that would be fantastic. It would be a dream come true for me after the many losses (FORW, BLEG, PAVS) this year... I have to admit, the latest news was fantastic; the company shouldn't be trading at this level and could soon see a massive surge—similar to how QBTS went from $0.50 to $20 years

knrorrel

knrorrel 50分前

$GPUS GPUS should make a magnificent, big, and sustained climb now; we just need a little patience, the ability to weather the fluctuations (ups and downs), and steady nerves. Ultimately, however, we should be trading in the multi-dollar range., all only imho

many great news &

nwtf

And why would we own this pos? You act like us knowing this is not a good investment is a bad thing?

knrorrel

knrorrel 51分前

$GPUS GPUS should make a magnificent, big, and sustained climb now; we just need a little patience, the ability to weather the fluctuations (ups and downs), and steady nerves. Ultimately, however, we should be trading in the multi-dollar range., all only imho

knrorrel

knrorrel 54分前

$GPUS many great news 🔥 strong undervalued https://www.otcmarkets.com/stock/GPUS/news

OTC Market Seite

https://www.otcmarkets.com/stock/GPUS/profile

knrorrel

knrorrel 54分前

many great news 🔥 strong undervalued https://www.otcmarkets.com/stock/GPUS/news

OTC Market Seite

https://www.otcmarkets.com/stock/GPUS/profile

nwtf

nwtf 1時間前

You are wrong here just as you were on the ERHE board spewing the same unproven narrative.

Ci Money Market Fund Ser...

Graniteshares 3x Short F...

Agf Us Smallmid Cap Fund...

WisdomTree Multi Asset I...

Monarch Volume Factor Gl...

Domestic bond 0.544% 7de...

Notes due 20/03/2043

Secure Property Developm...

Xtrackers II Eurozone Go...

Ci Emerging Markets Fund...

Embracer Group AB

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。